Brierley, D. I., Harman, J. R., Giallourou, N., Leishman, E., Roashan, A. E., Mellows, B. A. D., Bradshaw, H. B., Swann, J. R., Patel, K., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2019) Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. Journal of Cachexia, Sarcopenia and Muscle, 10 (4). pp. 844-859. ISSN 2190-6009 doi: https://doi.org/10.1002/jcsm.12426

Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2017) A cannabigerol-rich Cannabis sativa extract, devoid of ∆9-tetrahydrocannabinol, elicits hyperphagia in rats. Behavioural Pharmacology, 28 (4). pp. 280-284. ISSN 0955-8810 doi: https://doi.org/10.1097/FBP.0000000000000285

Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2016) Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 233 (19-20). pp. 3603-3613. ISSN 0033-3158 doi: https://doi.org/10.1007/s00213-016-4397-4

Brierley, D., Samuels, J., Duncan, M., Whalley, B. and Williams, C. ORCID: https://orcid.org/0000-0003-4452-671X (2016) Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. Psychopharmacology, 233 (2). pp. 243-254. ISSN 1432-2072 doi: https://doi.org/10.1007/s00213-015-4100-1